A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested.
Weight-loss drugs such as Ozempic and Wegovy have soared in popularity. About one in eight U.S. adults said they’ve taken a GLP-1 drug, used to treat type 2 diabetes and obesity, according to a Kaiser Family Foundation poll published in May 2024.
But like with any other drugs, there are side effects, including a newly found one that could interfere with medical imaging.
Researchers from Alliance Medical, a European imaging service provider, reviewed oncologic FDG PET-CT scans in patients taking GLP-1 drugs.
With an FDG PET scan, a patient…more
Source www.yahoo.com
FTC: We use income earning affiliate links. More on Sposored links.
Terms of use and third-party services. More here.
Terms of use and third-party services. More here.